{"body":"<ol><li>Ford N, Ball A, Baggaley R, Vitoria M, Low-Beer D, Penazzato M et al. The WHO public health approach to HIV treatment and care: looking back and looking ahead. Lancet Infect Dis. 2018;18:e76-86.<\/li>&#13;\n\t<li>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach - second edition. Geneva: World Health Organization; 2O16 (<a href=\"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/208825\/9789241549684_eng.pdf?sequence=1&amp;isAllowed=y\">https:\/\/apps.who.int\/iris\/bitstream\/ handle\/10665\/208825\/9789241549684_eng.pdf?sequence=1&amp;isAllowed=y<\/a>, accessed 1 June 2021).<\/li>&#13;\n\t<li>Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations - 2016 update. Geneva: World Health Organization; 2016 (<a href=\"http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/246200\/9789241511124-eng.pdf?sequence=8\">http:\/\/apps.who.int\/ iris\/bitstream\/handle\/10665\/246200\/9789241511124-eng.pdf?sequence=8<\/a>, accessed1 June 2021).<\/li>&#13;\n\t<li>Triple billion targets. Geneva: World Health Organization; 2020 (<a href=\"https:\/\/www.who.int\/news-room\/q-a-detail\/the-triple-billion-targets\">https:\/\/www.who.int\/ news-room\/q-a-detail\/the-triple-billion-targets<\/a>, accessed 1 June 2021).<\/li>&#13;\n\t<li>Understanding Fast-Track: accelerating action to end the AIDS epidemic by 2030. UNAIDS Geneva; 2015 (<a href=\"https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_Understanding_FastTrack_en.pdf\">https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/201506_JC2743_ Understanding_FastTrack_en.pdf<\/a>, accessed 1 June 2021).<\/li>&#13;\n\t<li>WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014 (<a href=\"https:\/\/www.who.int\/groups\/guidelines-review-committee\">https:\/\/www.who.int\/groups\/guidelines-review-committee<\/a>, accessed 1 June 2021).<\/li>&#13;\n\t<li>GRADE handbook. GRADE Working Group; 2013 (<a href=\"https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html\">https:\/\/gdt.gradepro.org\/app\/handbook\/ handbook.html<\/a>, accessed 1 June 2021).<\/li>&#13;\n\t<li>Baeten JM, Palanee-Phillips T, Mgodi NM, Mayo AJ, Szydlo DW, Ramjee G et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. Lancet HIV. 2021;8:e87-95.<\/li>&#13;\n\t<li>Nel A, van Niekerk N, Van Baelen B, Malherbe M, Mans W, Carter A et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. Lancet HIV. 2021;8:e77-86.<\/li>&#13;\n<\/ol>","title":"References","nid":503,"vid":2045,"created":1630942745,"changed":1630943059,"field_content_type":{"tid":1,"name":"Content","class":"content"}}